Hospital
Jacksonville Hospital LLC
Jacksonville Hospital LLC was paid $5.93M by Medicaid between Oct 2019 and Nov 2024, across 92 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.
33Billing provider infoJACKSONVILLE HOSPITAL LLC
JACKSONVILLE, TX 75766
JACKSONVILLE, TX 75766
33aNPI1730697350assigned 01/17/2018
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.93M
24GClaims72,884
24DCodes billed92
24AFirst – last monthOct 2019 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#31 of 109
Median peer was paid$1.15M
This provider vs. median5.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 15 | $2K | |
| 2020 | 1,378 | $75K | |
| 2021 | 15,955 | $950K | |
| 2022 | 25,521 | $1.85M | |
| 2023 | 21,800 | $1.97M | |
| 2024incomplete | 8,215 | $1.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 4,625 | 4,329 | $1.95M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 8,061 | 7,827 | $1.27M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 1,495 | 1,344 | $877K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.7% | 1,884 | 1,821 | $280K |
| 59025 | Fetal non-stress test | 3.0% | 535 | 333 | $178K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.0% | 2,869 | 2,754 | $121K |
| 71045 | Radiologic examination, chest; single view | 1.8% | 1,014 | 930 | $106K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 717 | 705 | $94K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 732 | 599 | $90K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 7,920 | 7,102 | $80K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 842 | 828 | $76K |
| 80053 | Comprehensive metabolic panel | 1.2% | 5,892 | 5,316 | $73K |
80 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.2% | 902 | $73K |
| 87400 | 1.1% | 845 | $64K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 576 | $58K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 977 | $54K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 978 | $54K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 380 | $41K |
| 87430 | <1% | 1,299 | $36K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 635 | $35K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 341 | $29K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,411 | $26K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 208 | $25K |
| 86703 | <1% | 902 | $20K | |
| 87807 | <1% | 709 | $19K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 177 | $14K |
| 86850 | <1% | 225 | $13K | |
| 87428 | <1% | 288 | $13K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,134 | $13K |
| 87340 | <1% | 773 | $12K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,087 | $12K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 30 | $11K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,068 | $11K |
| 80061 | Lipid panel | <1% | 769 | $8K |
| 85730 | <1% | 1,031 | $8K | |
| 85610 | <1% | 1,357 | $7K | |
| 84439 | <1% | 602 | $7K | |
| 86592 | <1% | 858 | $6K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 107 | $5K |
| 81001 | <1% | 1,347 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 52 | $4K |
| 81025 | <1% | 327 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 347 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 89 | $3K |
| 83690 | <1% | 370 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 115 | $3K |
| 99201 | <1% | 52 | $3K | |
| 86803 | <1% | 117 | $2K | |
| 81003 | <1% | 1,005 | $2K | |
| 84484 | <1% | 176 | $2K | |
| 84702 | <1% | 79 | $2K | |
| 76801 | <1% | 16 | $2K | |
| 82150 | <1% | 188 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 194 | $1K |
| 94664 | <1% | 16 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 12 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 35 | $1K |
| 94760 | <1% | 33 | $1K | |
| 82607 | <1% | 66 | $1K | |
| 86900 | <1% | 250 | $1K | |
| 86901 | <1% | 250 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 112 | $1K |
| 83880 | <1% | 38 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,176 | $938.97 |
| 82746 | <1% | 69 | $909.82 | |
| 87081 | <1% | 70 | $856.96 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 63 | $809.55 |
| 86787 | <1% | 26 | $614.30 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 15 | $514.27 |
| 82950 | <1% | 70 | $491.41 | |
| 83540 | <1% | 95 | $443.27 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $413.68 |
| 87040 | <1% | 45 | $377.26 | |
| 83605 | <1% | 69 | $366.90 | |
| 82105 | <1% | 13 | $285.30 | |
| 83550 | <1% | 37 | $233.05 | |
| 86038 | <1% | 13 | $231.71 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 16 | $220.30 |
| 82728 | <1% | 28 | $207.16 | |
| 84153 | <1% | 12 | $199.19 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 157 | $148.28 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 75 | $148.18 |
| 87077 | <1% | 22 | $142.44 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 16 | $127.92 |
| 83735 | <1% | 40 | $126.87 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 17 | $112.52 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $68.15 |
| 87210 | <1% | 39 | $39.97 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 16 | $29.14 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 14 | $25.43 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 87 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETROVICH, STEPHEN (EVP AND SECRETARY)
| Provider | Location | Paid |
|---|---|---|
| Lovelace Health System, LLC | Albuquerque, NM | $57.71M |
| Lovelace Health System LLC | Albuquerque, NM | $45.27M |
| Southwest Medical Associates, LLC | Albuquerque, NM | $41.40M |
| Lovelace Health System, LLC | Albuquerque, NM | $31.24M |
| Lovelace Health System LLC | Roswell, NM | $20.13M |
| Jacksonville Hospital LLC | Jacksonville, TX | $9.41M |
| Henderson Hospital, LLC | Henderson, TX | $8.52M |
| Athens Hospital, LLC | Athens, TX | $8.32M |
| Etmc Physician Group INC. | Tyler, TX | $8.03M |
| Tyler Regional Hospital LLC | Tyler, TX | $7.94M |
| Lovelace Unm Rehabilitation Hospital LLC | Albuquerque, NM | $6.30M |
| Pocatello Hospital LLC | Pocatello, ID | $6.11M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $5.61M |
| Bsa Hospital LLC | Amarillo, TX | $4.96M |
| Pittsburg Hospital LLC | Pittsburg, TX | $4.83M |
| Ahs Claremore Regional Hospital, LLC. | Claremore, OK | $4.81M |
| Ahs Henryetta Hospital LLC | Henryetta, OK | $4.27M |
| Pittsburg Hospital LLC | Pittsburg, TX | $3.98M |
| Topeka Hospital, LLC | Topeka, KS | $3.94M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $3.76M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.